Dr. Anna BŁOŃSKA, M.D., Ph.D.
She is a graduate of the Faculty of Medicine at Medical University in Wrocław.
She completed her specialist training at the Department and Clinic of Ophthalmology, obtaining the title of eye disease specialist after passing the State Specialization Exam in 2014.
Parallel to her specialist training, she conducted scientific research in the field of genetics as part of her doctoral studies at the Medical University of Wrocław and, as a recipient of a Kosciuszko Foundation scholarship, at Einstein University in New York. This work culminated in her doctoral dissertation in 2015, which she defended with honors, obtaining the title of Doctor of Medical Sciences.
In addition, she worked and conducted research for three years as a Postdoctoral Research Fellow at the Department of Ophthalmology at Columbia University in New York, focusing on genetically determined retinal diseases.
She is a co-author of publications in international ophthalmology journals, such as:
- Retina,
- IOVS (Invest Ophthalmol Vis Sci),
- Retin Cases Brief Rep,
- Archives of Ophthalmology,
- Prog Retin Eye Res,
and genetics journals, such as:
- Human Mutation,
- American Journal of Medical Genetics.
She is a regular reviewer of ophthalmological publications for IOVS.
The results of her work in the field of ophthalmology have been presented many times at ARVO (The Association for Research in Vision and Ophthalmology) conferences in the USA.
She has been working with OOK Spektrum since 2013, treating patients (adults and children) with a wide range of ophthalmic conditions, with a special interest in genetically determined retinal diseases, as well as corneal diseases, with particular emphasis on keratoconus.
She performs corneal crosslinking and photorefractive keratectomy (PTK) procedures.
Since 2024, she has also been working at the Medical Faculty of the Wrocław University of Technology as the head of the Medical Genetics Laboratory, conducting scientific research and lecturing to students.
She is constantly improving her qualifications by participating in conferences and training courses on ophthalmology and genetics. In 2025, she completed a 2.5-month training course at Harvard University and obtained a certificate of achievement in the clinical application of the latest genetic testing and sequencing technologies.
